arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked

Enhancing Value Delivery

Managing risk and seeking growth in the pharmaceutical industry

Princeton, New Jersey |
Speakers include:
Hannah Kuchler

Hannah Kuchler

Financial Times

Overview

The US pharmaceutical sector is on the cusp of significant change that will transform traditional business models and the ecosystems that companies, customers and regulators operate in. Faced with heightened attention from both the public and government, pricing is under pressure. The Trump administration recently proposed a plan to implement an International Pricing Index (IPI) for Medicare Part B products. Senator Bernie Sanders is advocating an International Reference Pricing (IRP) approach similar to Canada’s. Increasing calls for transparency on drugs pricing and healthcare costs are likely to precipitate a shift from a cost-per-service-used model to a value-driven, outcome-based model.

Drug manufacturers are therefore being compelled to adopt a sound and rigorous approach to fair market value that will help drive growth, improve operational efficiency and manage compliance risk. With Amazon gaining healthcare distributor licenses in at least a dozen states, new competitors are entering the already complex ecosystem of drug makers, healthcare providers, insurers and distributors. There has been a wave of integrations between pharmacy benefit managers (PBMs) and major insurers.

Healthcare providers are joining forces in not-for-profit initiatives with the aim of making essential generic medicines more widely available and more affordable. Meanwhile, some campaigners are calling for more drastic action, such as “Medicare for all,” which would eliminate the role of the PBM and result in a single-payer system. Digital transformation is accelerating “beyond the pill” strategies, with pharmaceutical companies providing technology-enabled services such as remote health monitoring sensors, telehealth services and chronic disease management to engage directly with patients and develop new holistic, connected solutions.

All of these trends are sending shock waves through the pharmaceutical industry. As it evolves, so will the nature of the legal, compliance and fraud risks that companies face. This FT Roundtable will bring together legal executives, chief compliance officers and other senior executives to discuss how to adjust to these changes, manage the risks and achieve profitable growth. 

fallback
fallback Add to my Calendar 05/08/2019 17:45:0005/08/2019 20:30:00falseEnhancing Value DeliveryThe US pharmaceutical sector is on the cusp of significant change that will transform traditional business models and the ecosystems that companies, customers and regulators operate in. Faced with heightened attention from both the public and government, pricing is under pressure. The Trump administration recently proposed a plan to implement an International Pricing Index (IPI) for Medicare Part B products. Senator Bernie Sanders is advocating an International Reference Pricing (IRP) approach similar to Canada’s. Increasing calls for transparency on drugs pricing and healthcare costs are likely to precipitate a shift from a cost-per-service-used model to a value-driven, outcome-based model.Drug manufacturers are therefore being compelled to adopt a sound and rigorous approach to fair market value that will help drive growth, improve operational efficiency and manage compliance risk. With Amazon gaining healthcare distributor licenses in at least a dozen states, new competitors are entering the already complex ecosystem of drug makers, healthcare providers, insurers and distributors. There has been a wave of integrations between pharmacy benefit managers (PBMs) and major insurers.Healthcare providers are joining forces in not-for-profit initiatives with the aim of making essential generic medicines more widely available and more affordable. Meanwhile, some campaigners are calling for more drastic action, such as “Medicare for all,” which would eliminate the role of the PBM and result in a single-payer system. Digital transformation is accelerating “beyond the pill” strategies, with pharmaceutical companies providing technology-enabled services such as remote health monitoring sensors, telehealth services and chronic disease management to engage directly with patients and develop new holistic, connected solutions.All of these trends are sending shock waves through the pharmaceutical industry. As it evolves, so will the nature of the legal, compliance and fraud risks that companies face. This FT Roundtable will bring together legal executives, chief compliance officers and other senior executives to discuss how to adjust to these changes, manage the risks and achieve profitable growth. Enhancing-Value-Delivery1771e02fa5cd3ed15de46188294c1e99MM/DD/YYYY

Agenda - 8th May

  • 5:45pm
    Guests arrive and drinks served
  • 6:15pm
    Welcome

    Hannah Kuchler, US pharmaceuticals and Biotech Correspondent, Financial Times

  • 6:25pm
    Opening remarks: How is disruption in the pharmaceutical industry forcing companies to rethink the role of their legal and compliance functions?

    Senior partner, EY 

  • 6:35pm
    Roundtable discussion: Adapting to change, managing risk and seeking growth
    • Shifting pricing models 
    • The evolving ecosystem
    • Managing risk
  • 7:25pm
    Closing remarks

    Hannah Kuchler, US Pharmaceuticals and Biotech Correspondent, Financial Times

  • 7:30pm
    Buffet and networking drinks
  • 8:30pm
    Event ends

Chair (1)

Hannah Kuchler

Hannah Kuchler

Financial Times

Hannah Kuchler is US Pharma and Biotech Correspondent for the Financial Times, with a particular focus on how technology is transforming healthcare. She is based in San Francisco.  For five years, Ms Kuchler served as FT’s San Francisco Correspondent where she covered Silicon Valley and technology with a focus on social media and cyber security. Ms Kuchler was previously a London-based UK news reporter for the FT, covering British politics and general UK news. Prior to this, she worked on the FT’s newsdesk, as Asia Correspondent for FT Tilt in Hong Kong, and covered US markets in New York.  Before joining the FT in 2009, Ms Kuchler was the Editor of The Oxford Student and won the Guardian’s Student Reporter of the Year award in 2008. She holds a Bachelor’s degree in Modern History from Balliol College, Oxford.

Presented by (1)

Financial Times Live (FT Live) is the global conferences and events division of the Financial Times Group. Chaired by senior journalists from the Financial Times Group, the summits, conferences, awards and strategic forums organised by FT Live gather the world’s brightest minds and most influential decision-makers.

Exclusive on-stage interviews, stimulating presentations and lively panel debates – available on multiple content platforms – provide the cutting-edge insights, unique personalities and peer audience engagement that have the power to transform finance, business, politics, society and culture.

The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. In 2016 the FT passed a significant milestone in its digital transformation as digital and services revenues overtook print revenues for the first time. The FT has a combined paid print and digital circulation of more than 910,000 and makes 60% of revenues from its journalism.

In association with (1)

About EY Forensic & Integrity Services

Dealing with complex issues of fraud, regulatory compliance and business disputes can detract from efforts to succeed. Better management of fraud risk and compliance exposure is a critical business priority — no matter the size or industry sector. With approximately 4,500 forensic professionals around the world, we will assemble the right multidisciplinary and culturally aligned team to work with you and your legal advisors. We work to give you the benefit of our broad sector experience, our deep subject-matter knowledge and the latest insights from our work worldwide.

Venue

Princeton Marriott at Forrestal
100 College Rd E
Princeton 08540

United States of America

Tel: +1 609-452-7800

fallback

Contact

Ruth Strachan
Content Executive
Financial Times